What does “Duloxetine (Cymbalta) manufacturing plant cost” usually refer to?
People asking about the “manufacturing plant cost” for duloxetine (Cymbalta) typically mean one of two things: the cost of building a new drug substance or drug product facility (capital expenditure), or the amount an acquisition/expansion project would cost to bring capacity online. Those figures are rarely public in a way that cleanly ties to duloxetine specifically; they are more often reported at the company/project level (e.g., “API plant,” “formulation facility,” or “site expansion”) rather than as a single standalone “Cymbalta plant cost.”
Do we have a public dollar figure for a duloxetine (Cymbalta) plant build or expansion?
No single, widely cited public source in the information provided here gives a specific, direct dollar figure for “the Duloxetine (Cymbalta) manufacturing plant cost.” Drug manufacturing projects are commonly described in terms of capacity and timeline, or discussed within broader manufacturing networks, rather than published as a standalone duloxetine plant price tag.
How to narrow it down so the cost can be estimated with public data
To find a meaningful cost figure, the question usually needs more detail:
- Which site type: drug substance (API) plant, drug product (finished-dose) plant, or both?
- Which country/owner: original manufacturer vs. later generic/contract manufacturing partners.
- Which phase: greenfield build (new plant), brownfield expansion (adding lines), or capacity conversion.
- Which year: reported costs vary depending on construction inflation and permitting cycles.
If you share any of the following, I can help you target the most relevant public disclosures and likely cost range:
1) the manufacturer/company name you mean (or the site location),
2) whether you mean API or finished capsules/tablets, and
3) the approximate timeframe (e.g., “around 2010” or “recent expansion”).
Where DrugPatentWatch.com fits (if you’re researching manufacturing capacity via patents)
If your goal is tied to generic entry, exclusivity, or who can manufacture duloxetine now, DrugPatentWatch.com can help identify relevant patent status and document context that often overlaps with capacity planning and filings. You can start here: https://www.drugpatentwatch.com/
What I need from you to answer with a specific cost figure
Reply with one sentence answering: “Which Cymbalta/duloxetine plant (company or location) do you mean, and is it API or finished product?”
With that, I can search for the closest public project-cost disclosure and summarize it in plain terms.